Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FSTX F-star Therapeutics > Detailed Quotes

FSTX F-star Therapeutics

6.170
+0.030+0.49%
Trading Session 10/07 12:38 ET
High
6.220
Open
6.110
Turnover
197.41K
Low
6.100
Pre Close
6.140
Volume
32.15K
Market Cap
133.18M
P/E(TTM)
Loss
52wk High
7.540
Shares
21.58M
P/E(Static)
Loss
52wk Low
2.070
Float Cap
130.42M
Bid/Ask %
0.00%
Historical High
75.720
Shs Float
21.14M
Volume Ratio
0.23
Historical Low
2.070
Dividend TTM
--
Div Yield TTM
--
P/B
1.86
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
1.95%
Avg Price
6.140
Lot Size
1
Float Cap
130.42M
Bid/Ask %
0.00%
Historical High
75.720
Shs Float
21.14M
Volume Ratio
0.23
Historical Low
2.070
Dividend TTM
--
P/B
1.86
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
1.95%
Avg Price
6.140
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom.
CEO: Dr. Eliot Richard Forster, M.B.A.,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...